chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a registered nurse regarding unknown number of patients with unknown demographics. Information on pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On unknown dates, unknown number of doses of GARDASIL 9 (lot# L043213 with expiry date: 28-AUG-2017, M003659 with 20-SEP-2017, M004116 with expiry date: 12-OCT-2017, M020103 with expiry date: 15-FEB-2018 and M021407 with expiry date: 30-APR-2018) (dosing details were not reported) were administered to an unknown number of patients following a temperature excursion of 33 F for 23 days. No adverse effects were reported. No product quality complaint was reported. This is one of the several reports. Additional information is not expected as there is no consent to contact the reporter.
Patient's first Vaccination given on 3/18/21.  Patient presented for second dose . Vaccination second dose was given nine days earlier than the recommended 28 day interval  on 4/6/21.
When he had each covid vaccine 1 & 2 ,  he had bad reactions becoming very ill and bed ridden for a couple days.  Then he recovered to full strength.  A month after the second vaccine, he collapsed. He went to the hospital via ambulance. The hospital determined  that he had strokes. He had additional strokes while in the hospital.  Then they admitted  him into the ICU. They administered multiple tests for 6 days. They determined sepsis with "vegetation" on his heart. He died on June 2, 2021.
I woke up and had chills and did not feel well, I ran a temperature of 101 degrees including body aches and joint aches. This lasted for two days.
My son was laying in my arms the evening of his vaccinations. He had 4 vaccinations administered. He cried much of the day and had a fever up to 102. While in my arms he had a seizure. We did not seem treatment. I spoke to a family member who is a nurse and I kept a close eye on my son. He was tired and a little weak afterward. The next day he didn't seem to have any remaining effects of the seizure. He is now nonverbal and has since been diagnosed with Autism.
I have received 3 doses Pfizer vaccine against Covid so far.  First dose (April 1, 2021) was uneventful. About 12-15 hours after the second dose 3 weeks later, I developed high fever with continuous sensation of palpitations. I checked my pulse, and noted a premature beat after each 4, or 8, or 12 normal beats. I do not have any cardiac history, and have not had ectopy before. I had some OTC magnesium at home (which I had used in the past very infrequently as an occasional sleep aid), which I took hoping to decrease ectopy - but shortly after that, the ectopy worsened, with doublets and triplets. This subsided over a couple of days, but repeated itself after the 3rd dose of Pfizer vaccine in Dec 2021. I have not had any Covid vaccines since then. The similar episodes of very frequent ectopy have repeated twice, in Jan 2022 and sometime in the spring 2023, when I had a sinusitis with fever, but I did not take a Covid test. I continue sometimes waking up in the morning with palpitations/ ectopic beats, which tend to resolve within less than an hour (and that is why I have checked below that the adverse event did not fully resolve).
Headache, Myalgia, Arthralgia, Fever, injection site pain Narrative: Employee reports experiencing injection site pain/discomfort, well as fever (102.2 F), chills, headaches, fatigue, nausea, body aches, and joint pain. Report using Tylenol for symptom relief.
Chest pain since 12/12/21, increasing in severity, became intolerable on 12/17/21.  Came to ED at Hospital.  Troponin elevated, trending up.  Diagnosed with probable vaccine induced cardiomyopathy
Immediately following vax, the pt felt "real bad". She experienced high temperature and an increased heart beat at 100 times a minute. It was indicated that her systolic blood pressure was recorded at 147, which normally is at 117. Therapy with antibiotics was initiated. The pt indicated that she lost her job due to her adverse experiences.
I received my 3rd dose of Moderna on 11/12/2021. I noticed a rash on upper arms in December 2021. In April of 2022, I received my second booster. In between the two doses of Moderna, I saw my doctor in regards to the rash on 03/14/2022. The doctor could not determine what the problem was but treated me for Scabies. On 4/14/2022, I had a follow up with my doctor who then determined that it was not Scabies but she prescribed a cream for the rash which helps, but as soon as I stop using the Triamcinolone Acetonide the rash returns.
inj site rt upper arm 9deltoid mild swelling, tenderness;pt c/o n/v, diarrhea p/vax;dx immunization rxn
Patient received flu vaccine, seizure activity noted within 5 minutes of receipt with loss of bladder and bowel control. Patient diaphoretic, pale with B/P of 90/58. Seizure activity noted for short periods of time (seconds) twice after initial seizure. Patient postictal transferred by ambulance to local hospital where he received fluid and a CT scan. He was released home the same day and ordered to restart seizure medication. (Patient had a history of seizure disorder but had not had a seizure in 10 years, patient was not on seizure medication.) He will follow-up with clinic.
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 75-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 17Sep2022 at 15:15 as dose 5 (booster), single (Lot number: GH9702) at the age of 75 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 19Feb2021 at 17:30 as dose 1, single (Lot number: EN6201), on 13Mar2021 at 17:00 as dose 2, single (Lot number: EN6208), on 05Oct2021 at 16:30 as dose 3 (booster), single (Lot number: 30135BA) and on 15Apr2022 at 12:00 as dose 4 (booster), single (Lot number: FK9729) for covid-19 immunisation. The patient's relevant medical history included: "Hyper active airway" (unspecified if ongoing); "reflux" (unspecified if ongoing); "IBS" (unspecified if ongoing); "Known allergies: Sulfa" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing); "known allergies; Rubber" (unspecified if ongoing); "known allergies; latex" (unspecified if ongoing), notes: known allergies; latex; "known allergies; alcohol" (unspecified if ongoing), notes: known allergies; alcohol. There were no concomitant medications. Past drug history included: Tetracycline, reaction(s): "Known allergies: tetracycline"; Nickel, reaction(s): "Known allergies: nickel".  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive; (30Sep2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.; Sender's Comments: Based on available information, a possible contributory role of Comirnaty vaccine cannot be excluded for the reported events of DRUG INEFFECTIVE and COVID-19.
Extreme stabbing lower right quadrant pain. Extreme pain in arm, neck, shoulder and back, also lower back. Severe vomiting. High fever,  chills, body pain, extreme lethargy, shortness of breath.
SHE DEVELOPED MILD CASE OF VARICELA AFTER 9 DAYS FROM RECIVIEING THE VARICELA VACCINE.
High fever and febrile seizure the evening after receiving vaccine.  Parent brought child to ER for evaluation.  Lab work performed.  Patient discharged home the same evening.
Information has been received from a registered nurse concerning a 69 year old female who on 17-APR-2008 was vaccinated with zoster vaccine live (Oka/Merck), 0.65 mL subcutaneously (lot # 659760/0159X). On 22-APR-2008, the patient developed an area of redness that was also itchy at the injection site. The area was about 2" X 4" in size. No other symptoms were noted. The patient called the medical doctor. The nurse reported that the patient was recovering.  09/24/2008 This is in follow-up to report(s) previously submitted on 6/24/2008. Additional information was received from the nurse concerning a retired female with a history of chickenpox with increased itchiness as a child who reported that the patient was vaccinated in the left arm with a first dose of ZOSTAVAX. It was reported that the patient called the office and reported that on 18-APR-2008 she got a reaction of redness, swelling, increased itchiness and a 2 x 3 area of hardness. The patient did seek medical attention in the doctor's office. The reaction lasted for ten days and the patient recovered on 28-APR-2008.
I woke up in pain, every joint, muscle, bone in my body hurt. I had a horrendous headache, chills, fever, and nausea. I couldn?t hardly get out of bed that day.  I felt like I had CoVid again. I continued to take my Tramadol with ibuprofen in between doses for pain. My symptoms lasted until the next day, where they started to ease up.  I had a doctors appointment that week, so I talked to my dr on my visit about it.
Within mins shooting pain on l side neck; Within mins shooting pain on l side neck; within 10hrs ER room severe chest pain; breathing issues; Severe sweeling l side of neck/chest/under arm; Severe sweeling l side of neck/chest/under arm; 2wks of breathing irregular heart beats; This is a spontaneous report from a contactable other health care professional (patient). A 52-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: unknown), intramuscular, administered in arm left on 09Sep2021 14:30 as dose 1, single (at the age of 52-years-old) for COVID-19 immunization. The patient was not pregnant at the time vaccination. Medical history included COVID-19 (covid prior vaccination: yes). The patient concomitant medications were not reported. The patient previously took Compazine [prochlorperazine edisylate] and experienced allergy. On 09Sep2021 14:45, within 15mins the patient experienced shooting pain on l side neck. within 10 hours of emergency room the patient had severe chest pain, breathing issues, severe swelling l side of neck/chest/under arm. The 2 weeks of breathing the patient had irregular heartbeats. The patient Still had severe/neck/chest/under arm swelling with severe pain. The events resulted in emergency room/department or urgent care. The patient received steroids as a treatment for the events. The patient underwent lab tests and procedures which included Nasal Swab: negative on 19Oct2021. The outcome of the events was not resolved.  The lot number for the vaccine, BNT162B2, was not provided and would be requested during follow up.
A non-serious spontaneous report of administration of expired FLUMIST was received from a health professional concerning an eight-year-old female. Neither the patient's past medical history nor the concomitant medications were reported. The product expired on 22-Nov-2010. The patient received the expired FLUMIST on 30-Nov-2010. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved.
This spontaneous report as received from a health care worker refers to multiple unspecified patients of unknown age and gender. The patients concurrent conditions and medical history were not reported. The healthcare worker reported that on an unknown date, multiple different unspecified patients received a dose of improperly stored VARIVAX (Merck) lot # L001326; expiry date: 13-JAN-2017 (dose and route not reported). No adverse effects were reported. No further information was provided. This case is one of the several reports from the same reporter. Additional inormation has been requested.
I was sitting down in the waiting area, reading an article and finished it about 40 minutes later.  When I looked up, I was unable to focus on any opject over about 30 feet away.  I got up and casually walked around and my ability to focus on distant objects became more clear.  I was well enough (75 minutes after shot) to leave the building.  I sat in my car for another 15 minutes to make sure that my vision was okay.
snycopy/fainting event with loss of consciousness, pale palor, weak pulse, shallow breathing. TX sternal rub, cold cloth patient awoke , with verbal stimuli  RN loudly saying are you ok you need to wake up,  then pt  was alert oriented x3  prior to losing consciousness he stated to his wife "I am going out," client has a HX of syncopy/fainting not shared with staff at covid 19 vaccine drive thru prior to vaccine administration.
Patient stated presently having left arm pain/discomfort with limited range of motion which has continued since vaccine administration.  Pt has taken both Tylenol 500mg & Ibuprofen 800mg at different times w/c would give her temporary relief. Hot/cold compresses have not been effective.
Patient was to be given a Moderna booster per provider verbal order. Patient was given a monovalent booster instead of a bivalent Pfizer booster that was on hand per facility protocol.  Patient was contacted 10/03/22 by nurse. Patient denies any adverse reactions. Provider was notified, per provider just inform patient to come back and receive bivalent dose.
Vaccine given in afternoon.  Patient felt heart palpitations during that night.  Blood pressure was 95/53; low for this patient.  Two hours later everything was fine.   Moderna Lot #016M20A
Swelling/redness at injection site. Prickly, itchy rash on entire body.
Bells palsey on left side. Had stiff neck several days before with first shot and more with second shot that escalated to bells palsey.
Pt recv vax in July'97; in Aug '97 pt exp swollen glands, fever, cough, malaise &sinus pain. Dx=Epstein-Barr virus;pt tx Famvir; pt imp.  In September '97 sxs reoccurred w/o fever; dx=herpes in blood.
FELT LIKE SHIT FOR 2 DAYS; CHILLS; FEVER; HEADACHE; MUSCULAR PAIN; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknow) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced felt like shit for 2 days, chills, fever, headache, and muscular pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from felt like shit for 2 days, chills, fever, headache, and muscular pain. This report was non-serious.
Patient developed rash approximately 1 hour after administration of the flu shot. Rash itchy, welps. Resolved after benadryl administration at the emergency department at Hospital.
raised, red, hot bump 2.5 inches long and 2 inches wide very itchy.  stiff arm and neck.  started 7 days post injection  a dime sized bump has been at injection site since injection but increased size, redness heat and itching are new
throat itching, facial swelling, allergic reaction  requiring Epipen, Benadryl, Solumedrol and monitoring
Varicella vaccine administered on 08/14/17, 5 days later had a local reaction at injection site, since then has been getting new lesion on arms, legs, abdomen, back and face.  Seen in Occupational Health on 8/31/17 and referred to Dermatology, was seen by Dermatology on 8/31/17 and confirmed it was chicken pox.  She was started on Valacyclovir 1000mg Q12.
Five hours after shot the back of my right eye was hurting the next day 03/12/2021 my right side from my head down to my lower back was hurting 03/15/2021 now my right arm is swollen And hurts to the touch and is feverish really hot And sore.
This spontaneous report was received from a physician via company representatives and from a support services director concerning to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications was not reported. On 19-NOV-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23, "10PK-0.5ml SD-PFS LLok wTip" which had the lot # K009874 with expiration date 19-MAR-2016 (dosage number and route of administration were not reported). On an unspecified date, the vaccine had a temperature excursion for 40 hours in which the highest recorded temperature was 47 degrees Fahrenheit (8.333333333 degrees Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse effects were reported and no product quality complaint was involved. This is one of the several reports received from the same reporter. Additional information has been requested.
Pt vaccinated at 10:36 am, at approximately 10:54am, pt states she is having "chest pain and pressure, 4 on 1-10 scale" refused EMS evaluation. VS assessed 97% o2, Hr 88, BP 137/99, R 18, T 97.1. States pain has been on and off since one day post first vaccine dose and has not been evaluated by MD. Dr. made aware at 11am. VS reassessed 113/56, P 76, R 18, o2 99%. "pain subsided" advised to seek medical attention should pain return, AMA executed due to refusing further medical evaluation. Left in no acute distress accompanied by driver and 2 other passengers,
hive-like rash; streaking and scratch like in presentation. Blanches with touch. Itches at times but not all the time. Very present on scalp, arms, wrists, knuckles, chest, back and groin. Intermittently present.
This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID-19) and ALOPECIA (Hair loss) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis. Concurrent medical conditions included Rheumatoid arthritis and Sjogren's syndrome. Concomitant products included UPADACITINIB (RINVOQ) for Rheumatoid arthritis and Sjogren's syndrome. On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In January 2022, the patient experienced COVID-19 (COVID-19). On an unknown date, the patient experienced ALOPECIA (Hair loss). At the time of the report, COVID-19 (COVID-19) outcome was unknown and ALOPECIA (Hair loss) had not resolved. Company comment: This is a spontaneous case concerning a 69-year-old female patient with medical history of Rheumatoid arthritis and Sjogren´s syndrome, who experienced the non-serious COVID-19,  within one to two months after the third dose of mRNA-1273. Clinical course, diagnostic tests and treatment details were not provided. Hear loss was reported as a non-serious event. The benefit-risk relationship of mRNA-1273 is not affected by this report. No treatment medications was provided by the reporter. It was unknown if patient was enrolled in a COVID-19 vaccine trial. Sender's Comments: Company comment: This is a spontaneous case concerning a 69-year-old female patient with medical history of Rheumatoid arthritis and Sjogren´s syndrome, who experienced the non-serious COVID-19,  within one to two months after the third dose of mRNA-1273. Clinical course, diagnostic tests and treatment details were not provided. Hear loss was reported as a non-serious event. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Patient developed spells of adrenaline rushes during sleep causing frequent waking. She developed difficulty with activities that caused elevated heart rate (cardiac deconditioning). Muscle fasciculations.
Information has been received from a 67 year-old female consumer with no pertinent medical history and with allergy to aspirin reporting on herself. On approximately 13-JUN-2013 ("two weeks ago"), the patient was placed on therapy with PNEUMOVAX 23 (dose, route and lot # not reported). Concomitant medications included ranitidine and pantoprazole 40 mg. It was reported that, on 13-JUN-2013 (two weeks ago), the patient experienced severe pain in her right arm after receiving PNEUMOVAX 23. No treatment for the pain was reported. No lab test were performed. The patient sought a medical attention by a phone call to her doctor. At the time of the report, the patient was recovering from the pain in her arm. Relatedness for severe pain in her arm was not reported for PNEUMOVAX 23. Additional information is not expected.
Developed malaise, generalized pain, particularly in the back, & temp of 105F, also developed hematemesis, hematuria, & leukopenia w/monocytosis;
administration_date=22Jan2021, dose_number=2/administration_date=30Dec2020, dose_number=1; Swollen and tenderness in tongue; Swollen and tenderness in tongue; Tender gums; soreness on right side of neck under ear; This is a spontaneous report from a contactable other hcp (patient). A 40-year-old female patient received second dose of bnt162b2 (lot number: EL3246), intramuscularly at arm left on 22Jan2021 15:00 at single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient historical vaccine included first dose of bnt162b2 (lot number: EH9899) intramuscularly at left arm on 30Dec2020 15:00 for covid-19 immunisation. Not Pregnant at the time of vaccination. The patient receive no other vaccines within 4 weeks prior to the COVID vaccine. No any other medications the patient received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced swollen and tenderness in tongue. Tender gums and soreness on right side of neck under ear, from 24Jan2021 08:00 AM. The adverse event result in doctor or other healthcare professional office/clinic visit. Treatment received for the adverse event included Prednisone and Pepcid. The outcome of the events was recovering.